Get Your Personalized Supplement StackSupplement Stack Quiz

Biovin Grape Extract

Also known as: Biovin Grape Extract, BioVin® French Red Grape Extract, grape seed extract (GSE), Vitis vinifera extract

Overview

Biovin Grape Extract is a full-spectrum botanical extract derived from the juice, seeds, and skins of French red grapes (Vitis vinifera). It is standardized to contain at least 5% trans-resveratrol and 40% grape oligomeric proanthocyanidins, along with other polyphenols like viniferins, polydatin, quercetin, gallic acids, and catechins. Primarily used for its antioxidant properties, it supports healthy aging, mitochondrial health, brain function, and gut microbiota. While individual grape polyphenols and grape seed extracts have been extensively studied, specific research on Biovin itself is moderate, with existing evidence from in vitro, animal, and human studies supporting its role as an antioxidant and anti-inflammatory agent. It is a non-GMO and vegan supplement.

Benefits

Biovin Grape Extract offers significant antioxidant benefits, as demonstrated in a human study where 375 mg/day for 4 weeks increased antioxidant potential in blood. A systematic review and meta-analysis of grape polyphenol-containing products, though not specific to Biovin, showed significant reductions in oxidative stress biomarkers. Related grape seed extract exhibits anti-cancer effects by inhibiting cancer cell proliferation and inducing apoptosis via mitochondrial pathways and reactive oxygen species modulation. These benefits extend to healthy individuals and those with chronic conditions like cardiovascular risk factors and type 2 diabetes. While specific effect sizes vary by dose and duration, statistically significant improvements in oxidative stress markers have been reported, with antioxidant effects observed within 4 weeks of supplementation.

How it works

Biovin Grape Extract exerts its effects primarily through its rich polyphenol content. These polyphenols act as potent antioxidants by scavenging free radicals and modulating reactive oxygen species (ROS) generation. They interact with cellular antioxidant defense systems and support mitochondrial function. In cancer cells, grape polyphenols, particularly those found in grape seed extract, have been shown to influence cellular apoptosis pathways and mitochondrial membrane potential. The diverse array of polyphenols in a full-spectrum extract like Biovin may offer synergistic effects, potentially enhancing absorption and overall biological activity within the body's systems, including brain and gut function.

Side effects

Biovin Grape Extract is generally considered safe at studied dosages, with no significant adverse events reported in human trials. Common, uncommon, or rare side effects have not been documented. However, due to its polyphenol content, there is a potential for interaction with anticoagulants, though specific data for Biovin is lacking. Caution is advised for individuals on blood thinners. No specific contraindications have been identified. Data on its use in special populations, such as pregnant or lactating women, is limited, and therefore, caution is recommended for these groups.

Dosage

For antioxidant effects, a human study utilized 375 mg/day of Biovin. Optimal dosage ranges are not well-established, but meta-analyses of grape polyphenols often include doses from 100 to 500 mg/day. The maximum safe dose is not clearly defined, but doses up to 500 mg/day of polyphenols are generally well tolerated. Daily dosing is recommended, with benefits typically observed after at least 4 weeks of consistent use. For full-spectrum effects, a standardized extract containing at least 5% trans-resveratrol and 40% oligomeric proanthocyanidins is recommended. Polyphenol bioavailability can be enhanced when taken with food, and co-administration with fats may further improve absorption. No specific cofactors are required.

FAQs

Is Biovin safe for long-term use?

Current evidence supports safety at studied doses for at least 4 weeks; however, long-term safety data is limited.

How soon can benefits be expected?

Antioxidant effects have been observed after 4 weeks of consistent supplementation.

Does Biovin contain only resveratrol?

No, Biovin is a full-spectrum extract containing various grape polyphenols, including resveratrol derivatives and proanthocyanidins.

Can Biovin help with cancer?

Preclinical studies suggest grape seed polyphenols have anti-cancer effects, but clinical evidence in humans is currently lacking.

Is Biovin better than isolated resveratrol?

Full-spectrum extracts like Biovin may offer complementary benefits beyond isolated resveratrol due to the synergistic effects of multiple polyphenols.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/19281340/ – This study evaluated Biovin at 375 mg/day in 14 healthy adults over 4 weeks, demonstrating dose-dependent antioxidant effects in vitro and increased antioxidant capacity in vivo. The small sample size limits the generalizability of these findings.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7971097/ – This systematic review and meta-analysis of various grape polyphenol-containing products (totaling over 500 participants) found significant reductions in oxidative stress biomarkers. While heterogeneity was noted, the overall quality of evidence was moderate to good, supporting the antioxidant efficacy of grape polyphenols.
https://www.qualialife.com/formulation/biovin-french-red-grapes-extract – This source provides information on Biovin as a full-spectrum extract from French red grapes, standardized to contain specific levels of trans-resveratrol and oligomeric proanthocyanidins, highlighting its comprehensive polyphenol profile and potential for synergistic bioactivities.
https://www.walshmedicalmedia.com/open-access/anticancer-effects-of-grape-seed-extract-on-human-cancers-a-review-2157-2518-S8-005.pdf – This review summarizes multiple in vitro and animal studies on grape seed extract's anticancer effects, detailing its mechanisms such as mitochondrial-mediated apoptosis and ROS modulation in cancer cells. It emphasizes strong mechanistic insights but notes the absence of direct clinical trials in cancer patients.